H1N1 influenza vaccine: Global access for a global problem

H1N1 influenza vaccine: Global access for a global problem.

Swine influenza A (H1N1) strikes a potential for global disaster

As of April 25(th)2009, 11.00 AM, eight human cases of swine influenza A virus infection have been identified in the United States in California and Texas. There is also established evidence of similar cases across the United States border in Mexico. Experts from the Centers for Disease Control and Prevention in cooperation with World Health Organization and public health experts from Canada an...

Potential for a global dynamic of Influenza A (H1N1)

BACKGROUND Geographical and temporal diffusion patterns of a human pandemic due to Swine Origin Influenza Virus (S-OIV) remain uncertain. The extent to which national and international pandemic preparedness plans and control strategies can slow or stop the process is not known. However, despite preparedness efforts, it appears that, particularly in the USA, Mexico, Canada and the UK, local chai...

WHO supports fair access to influenza A (H1N1) vaccine.

Dr Marie-Paule Kieny is director of the Initiative for Vaccine Research at the World Health Organization (WHO). She received a degree in Economics in 1977, followed by a PhD in microbiology in 1980, both from the University of Montpellier in France. Her research career began with the development of a recombinant rabies vaccine. Since then, she has worked on the design of AIDS vaccine candidates...

O1: Anxiety As a Global Problem

Several investigations demonstrated that anxiety is the most common mental health disorder worldwide affected about one in 13 people. Anxiety disorders are more commonly reported in Western societies but it is also a main health problem in non-Western countries as stress and anxiety levels have drastically increased over the last two decades. Several wars in Middle Eastern countries in the last...